Sponsor Check › Person
Named as an officer, director or promoter on SEC Form D filings · PA, MA · Sep 29, 2009 → Sep 23, 2021
Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET
Peter Barrett is listed as an executive officer and director on 26 SEC Form D filings by 12 issuers between Jun 2009 and Sep 2021. Largest by amount reported sold: PERKINELMER INC (Waltham, MA — other health care — 2021; $2.2B reported sold to 61 investors), Larimar Therapeutics, Inc. (Bala Cynwyd, PA — biotechnology — 2010–2020; $82.1M reported sold to 24 investors), SYNLOGIC, INC. (Cambridge, MA — biotechnology — 2019; $80M reported sold to 24 investors), SYNLOGIC, INC. (Cambridge, MA — biotechnology — 2014–2017; $42M reported sold to 16 investors), Obsidian Therapeutics, Inc. (Cambridge, MA — biotechnology — 2017; $32.4M reported sold to 8 investors) and 7 more (all listed below).
What this means That is a lot of deals — 12 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $2.5B sold in total.
Listed alongside Bruce Booth (6 shared filings), Dan Burns (6 shared filings), Harold Werner (6 shared filings), Patrick Enright (6 shared filings), Robert Vukovich (6 shared filings) and 88 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
The issuers belong to 2 sponsor groups: Synlogic (3 issuers, $139.1M reported sold, 2011–2019) and Atlas Venture (11 issuers, $2.66B reported sold, 2011–2026).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 8 bankruptcy cases matching the name listed in Key records below.
What this means 8 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 26 public filings for Peter Barrett and found 15 differences, 4 worth asking the sponsor about: Regulator action naming a team member: Ankit Mahadevia and Satyavrat Shukla (Jan 16, 2026); 4 bankruptcy cases name the subject or team members; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.
Community search for Peter Barrett has not run yet — it is joining a line of 24,700 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.
Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).
Five things investors ask first. Items still in human review are counted, not shown.
None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Peter Barrett..
State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).
8 cases: 8 closed (disposition not in docket feed)
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.
Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.
State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons cover issuers and sponsor groups — see the issuer pages under Deals
15 differences found between the filings for Peter Barrett — 4 worth asking about (compared 26 filings on Oct 24, 2026)
A ap release dated Jan 16, 2026 names Ankit Mahadevia (listed on the same filings). The release is the source; we do not summarize its outcome here.
What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.
Bankruptcy case: Christina L. Barrett and Peter J. Barrett — filed Jul 22, 1997 · Bankruptcy case: Helicos Biosciences Corporation — filed Nov 15, 2012 · Bankruptcy case: Helicos Biosciences Corporation v. Atlas Venture Fund VI, L.P. — filed Jun 26, 2014 · Bankruptcy case: Khuong Tran and Vien T. Nguyen — filed Oct 14, 2003
What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.
The Feb 4, 2010 Form D/A reports $12,755,376 sold and $2,500,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
The Jan 11, 2010 Form D reports $12,500,000 sold and $2,500,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).
What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.
Synlogic, LLC (last filing Feb 26, 2016; $17,116,500 sold of $40,594,970); Atlas Venture Fund X, L.P. (last filing Dec 18, 2014; $0 sold of $250,000,000); Stromedix Inc (last filing Jan 25, 2011; $2,000,000 sold of $15,500,000). Each has no filing in more than two years and reported under half its target sold.
What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.
MTS Partners is listed as receiving sales compensation on 1 filing (Jun 10, 2020) with no FINRA CRD number given.
What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.
No amendment in the last 12 months on an offering that may still be open — Obsidian Therapeutics, Inc. (latest filing Dec 8, 2017) · No amendment in the last 12 months on an offering that may still be open — INFACARE PHARMACEUTICAL CORP (latest filing Jun 7, 2017) · No amendment in the last 12 months on an offering that may still be open — INFACARE PHARMACEUTICAL CORP (latest filing Nov 4, 2016) · No amendment in the last 12 months on an offering that may still be open — Synlogic, LLC (latest filing Feb 26, 2016) · No amendment in the last 12 months on an offering that may still be open — SYNLOGIC, INC. (latest filing Jul 22, 2014) · and 7 more
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
"Other Health Care" (Mar 1, 2010 to Dec 5, 2012); then "Biotechnology" (Jun 10, 2020 to Jun 10, 2020).
What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.
This page covers filings where the address state is PA or MA. A separate record, "Peter Barrett" with address state CA, is listed on 26 filings — most recently by Playground Ventures IV, L.P. (Jul 2, 2026). Both records have filings in the same period (Apr 6, 2015 to Sep 23, 2021).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is PA or MA. A separate record, "Peter Barrett" with address state NY, is listed on 1 filing — most recently by Bingham Natural Wines, LLC (Sep 18, 2017). Both records have filings in the same period (Sep 18, 2017).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is PA or MA. A separate record, "Peter Barrett" with address state RI, is listed on 2 filings — most recently by Mnemosyne Pharmaceuticals Inc (Feb 4, 2015). Both records have filings in the same period (Jul 3, 2013 to Feb 4, 2015).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is PA or MA. A separate record, "Peter Barrett" with address state DE or CO, is listed on 3 filings — most recently by JenaValve Technology Inc (Aug 7, 2015). Both records have filings in the same period (Jul 24, 2013 to Nov 14, 2014).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
This page covers filings where the address state is PA or MA. A separate record, "Peter Barrett" with address state FL, is listed on 1 filing — most recently by Sirion Holdings, Inc. (Oct 27, 2009). Both records have filings in the same period (Oct 27, 2009).
What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.
The people listed on the Dec 5, 2012 filing give Cambridge, MA; on the Jun 10, 2020 filing they give Bala Cynwyd, PA.
What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.
PA on 9 filings (Jun 10, 2009 to Jun 10, 2020); MA on 17 filings (Sep 29, 2009 to Sep 23, 2021).
What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.
What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.
2 of 24 offerings report sales commissions totalling $5,287,750; 0 report finder's fees; 7 report proceeds to related persons totalling $4,136,000. (includes amounts the issuer reported as estimates)
| Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it | Source |
|---|---|---|---|---|---|
| Sep 23, 2021 D PERKINELMER INC File 021-414448 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 10, 2020 D Larimar Therapeutics, Inc. File 021-368640 | $4,800,000 (est.) | $0 | $0 | MTS Partners no CRD number reported | EDGAR ↗ |
| Jun 10, 2020 D Larimar Therapeutics, Inc. File 021-368642 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 18, 2019 D SYNLOGIC, INC. File 021-342188 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Dec 8, 2017 D Obsidian Therapeutics, Inc. File 021-300326 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jun 7, 2017 D INFACARE PHARMACEUTICAL CORP File 021-288227 | $0 | $0 | $293,000 (est.) Amount to be paid to related person represents ordinary salary, excluding fringe costs. | None listed on this filing | EDGAR ↗ |
| May 26, 2017 D SYNLOGIC, INC. File 021-287588 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Nov 4, 2016 D INFACARE PHARMACEUTICAL CORP File 021-273838 | $0 | $0 | $350,000 (est.) Amount to be paid to related person represents ordinary salary, excluding fringe costs. | None listed on this filing | EDGAR ↗ |
| Feb 26, 2016 D Synlogic, LLC File 021-258209 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 26, 2016 D Synlogic, LLC File 021-258214 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 8, 2015 D INFACARE PHARMACEUTICAL CORP File 021-243247 | $0 | $0 | $600,000 Amount to be paid to related persons represents ordinary salary, excluding fringe costs. | None listed on this filing | EDGAR ↗ |
| Dec 18, 2014 D Atlas Venture Fund X, L.P. File 021-230375 | $0 | $0 | $0 An Affiliate of the General Partner will receive a management fee payable by the Issuer quarterly in advance as specified in the Issuer's partnership agreement. | None listed on this filing | EDGAR ↗ |
| Dec 9, 2014 D INFACARE PHARMACEUTICAL CORP File 021-229740 | $0 | $0 | $100,000 (est.) Amount to be paid to related persons represents ordinary salary, excluding fringe costs. | None listed on this filing | EDGAR ↗ |
| Oct 21, 2014 D INFACARE PHARMACEUTICAL CORP File 021-226833 | $0 | $0 | $48,000 (est.) Amount to be paid to related persons represents ordinary salary, excluding fringe costs. | None listed on this filing | EDGAR ↗ |
| Jul 22, 2014 D SYNLOGIC, INC. File 021-221509 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 20, 2013 D INFACARE PHARMACEUTICAL CORP File 021-193657 | $0 | $0 | $245,000 (est.) Amount to be paid to related persons represents ordinary salary, excluding fringe costs. | None listed on this filing | EDGAR ↗ |
| Dec 5, 2012 D Larimar Therapeutics, Inc. File 021-187910 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Aug 28, 2012 D Larimar Therapeutics, Inc. File 021-183316 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Jul 12, 2011 D Larimar Therapeutics, Inc. File 021-162666 | $0 | $0 | $0 (est.) | None listed on this filing | EDGAR ↗ |
| Jan 25, 2011 D Stromedix Inc File 021-154307 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Mar 2, 2010 D/A Larimar Therapeutics, Inc. File 021-94401 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
| Feb 4, 2010 D/A MOLECULAR BIOMETRICS INC File 021-123566 | $0 | $0 | $2,500,000 (est.) | None listed on this filing | EDGAR ↗ |
| Sep 29, 2009 D HELICOS BIOSCIENCES CORP File 021-61335 | $487,750 | $0 | $0 | THOMAS WEISEL PARTNERS LLC BrokerCheck CRD 46237 ↗ | EDGAR ↗ |
| Jun 10, 2009 D Vitae Pharmaceuticals, Inc File 021-56589 | $0 | $0 | $0 | None listed on this filing | EDGAR ↗ |
Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
Every issuer that named Peter Barrett on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.
Raised $2.2B from 61 investors (100% of the $2.2B target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $82.1M from 24 investors (100% of the $82.1M target) as of the latest filing. Peter is listed as director on 7 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $80M from 24 investors (100% of the $80M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $32.4M from 8 investors (65% of the $49.9M target) as of the latest filing. Peter is listed as executive officer, director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $12.1M from 11 investors (100% of the $11M target) as of the latest filing. Peter is listed as director on 6 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $42M from 16 investors (100% of the $42M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $17.1M from 3 investors (100% of the $17.1M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
No sales reported yet as of the latest filing. Peter is listed as executive officer.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Raised $2M from 9 investors (13% of the $15.5M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $12.8M from 16 investors (75% of the $17M target) as of the latest filing. Peter is listed as director on 2 filings for this deal.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $10M from 25 investors (100% of the $10M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Raised $15M from 1 investor (100% of the $15M target) as of the latest filing. Peter is listed as director.
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.
Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.
Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Bruce Booth is on 21 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Mitchell S. Bloom is on 12 issuers in total — a repeat sponsor. Their page lists every one.
Kevin Starr is on 9 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Lewis Geffen is on 8 issuers in total — a repeat sponsor. Their page lists every one.
Chau Khuong is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Ed Mathers is on 13 issuers in total — a repeat sponsor. Their page lists every one.
Louis Tartaglia is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Ankit Mahadevia is on 6 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Nick Leschly is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Jonathan Fleming is on 15 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Lou Tartaglia is on 5 issuers in total — a repeat sponsor. Their page lists every one.
Michael Gilman is on 7 issuers in total — a repeat sponsor. Their page lists every one.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
Listed on the same filings as Peter Barrett. Their page shows their other deals.
One team, 3 deal companies. Peter Barrett is listed on 3 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Barrett.
One team, 11 deal companies. Peter Barrett is listed on 1 of them.
Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Peter Barrett.
A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.
None of the 12 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Property records are matched to companies only, never to individuals, so none are matched to Peter Barrett by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 12 issuers this person is listed on — nothing matched.
Websites and social links of the issuers Peter Barrett is listed on: none on file. No website or social profile named in PERKINELMER INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #180,048 of 374,652 in line (1,253 issuers searched so far). One-tap searches: Look further ↓
One-tap searches on sites we do not index ourselves, with the name pre-filled (Waltham, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Peter Barrett appears on a new Form D, or when a court case or SEC action is matched to them. See plans →
